U.S. Media Stock News

Six Flags Entertainment (FUN) stock recently reacted to first quarter results, as revenue reached US$225.63 million on attendance up 4% and per capita spending up 6%, with net revenue rising 12%. See our latest analysis for Six Flags Entertainment. The Q1 beat on revenue and improving attendance appears to have sparked fresh interest, with the share price up 42.09% year to date and 21.87% over 90 days, although the 1 year total shareholder return is still down 42.28%, pointing to momentum...

Viasat (VSAT) added two independent directors, Shekar Ayyar and Jinhy Yoon, to its Board and Strategic Review Committee as part of a cooperation agreement with Carronade Capital and aligned investors focused on core assets. See our latest analysis for Viasat. The latest board changes come as momentum in Viasat’s stock remains strong, with the share price at US$70.01 and a 90 day share price return of 55.58%, while the 1 year total shareholder return is very large at around 7x. If this kind of...

In early May 2026, Fidelity National Financial reported first-quarter 2026 results showing higher revenue of US$3,226 million and net income of US$243 million compared with the prior year, affirmed a quarterly dividend of US$0.52 per share for payment on June 30, 2026, and filed a shelf registration for future debt securities offerings. Alongside these developments, the company emphasized expanding AI and technology use to improve title operations and margins while proposing annual director...

In April 2026, PROCEPT BioRobotics Corporation reported first-quarter 2026 results showing sales of US$83.13 million versus US$69.16 million a year earlier, alongside a wider net loss of US$31.64 million and basic loss per share of US$0.56. At the same time, the company reaffirmed its full-year 2026 outlook, including expected revenue of US$390 million to US$410 million and a net loss range of US$78.50 million to US$91.50 million, underlining management’s confidence in its growth plans...

In early May 2026, The Estée Lauder Companies reported third-quarter fiscal 2026 sales of US$3,712 million and net income of US$89 million, narrowed its full-year EPS outlook to US$0.69–US$0.83, flagged a 2% sales headwind for the fourth quarter, affirmed a US$0.35 dividend, and continued addressing legal issues including data-breach and shareholder settlements. At the same time, the company moved ahead with a broad restructuring that includes cutting nearly 20% of its global workforce while...

In recent weeks, Hims & Hers Health launched its Labs AI agent to help users interpret biomarker lab results, expanded access to branded GLP-1 weight-loss drugs through partnerships with Novo Nordisk and Eli Lilly, and confirmed upcoming board changes that will reduce its board size to nine directors while retaining its Global Chief Medical Officer. Together, these moves highlight how Hims & Hers is leaning on AI-enabled care and branded obesity treatments to deepen patient engagement and...

XPEL (XPEL) stock is back in focus after first quarter 2026 results topped analyst expectations, with revenue of US$117.35 million and earnings per share of US$0.37, along with higher second quarter revenue guidance. See our latest analysis for XPEL. Despite the earnings beat and higher Q2 revenue guidance, XPEL's short term share price momentum has been weak. The stock is down over the past week, quarter, and year to date, even as the 1 year total shareholder return remains positive and...

We wouldn't blame Antero Midstream Corporation ( NYSE:AM ) shareholders if they were a little worried about the fact...

Bicara Therapeutics has reported first-quarter 2026 results showing a wider net loss of US$56.21 million, with basic and diluted loss per share from continuing operations at US$0.93, up from US$0.68 a year earlier. At the same time, institutional investors such as FMR LLC and Red Tree have disclosed mid single-digit percentage stakes, highlighting growing professional interest even as losses increase. We’ll now examine how this larger quarterly loss, against Bicara’s earlier growth...

NewAmsterdam Pharma Company N.V. has reported first-quarter 2026 results, posting US$3.04 million in sales and a net loss of US$48.44 million, while outlining ongoing Phase 3 programs for its lead drug obicetrapib. Investors also heard that an interim analysis of the PREVAIL cardiovascular outcomes trial is planned for late 2026, alongside pending European regulatory decisions and potential initial commercial launches of obicetrapib by Menarini. We will now examine how the planned PREVAIL...

Sally Beauty Holdings, Inc. has released its second-quarter 2026 results, reporting sales of US$903.38 million and net income of US$42.7 million, with both revenue and earnings per share rising compared with the same period a year earlier. While second-quarter performance improved year over year, the company’s net income for the first six months slipped to US$88.25 million, highlighting a contrast between recent quarterly momentum and softer results over the broader half-year period. We’ll...

Amer Sports stock performance snapshot Amer Sports (NYSE:AS) has drawn investor attention after recent trading, with the stock last closing at US$36.03. Short term performance has been mixed, including a daily decline alongside a gain over the past week. See our latest analysis for Amer Sports. While the 1-day share price return declined 1.26% and the 90-day share price return is down 10.37%, the 1-year total shareholder return of 19.94% points to underlying momentum that has held up over a...

In the past quarter ended March 31, 2026, International Paper reported sales of US$5,971 million, net income of US$60 million, and earnings per share of US$0.11, reversing losses from a year earlier. Despite this return to profitability, management highlighted that margins remain under pressure from inflation, higher energy costs, and transformation-related expenses amid softer packaging demand in key regions. Next, we will examine how International Paper’s return to profitability but...

In late April 2026, Tenable Holdings reported first-quarter results showing revenue of US$262.06 million and net income of US$1.41 million, while also updating guidance, product packaging, and share repurchases. The combination of a move to profitability, higher full-year guidance, and new flexible pricing for its Tenable One platform gave investors fresh insight into how the exposure management business is evolving. We’ll now examine how Tenable’s shift to profitability and raised full-year...

UMB Financial (UMBF) is back in focus after a strong first quarter, with higher net interest income, higher net income, and lower net charge offs, alongside a bullish golden cross technical signal. See our latest analysis for UMB Financial. At a share price of $131.36, UMB Financial’s recent 1 month share price return of 9.26% and year to date share price return of 12.77% sit alongside a 1 year total shareholder return of 24.25%. This reflects momentum around its first quarter results,...

BXP, Inc. reported first-quarter 2026 results showing revenue of US$872.15 million and net income of US$101.58 million, and raised its full-year 2026 EPS guidance to US$2.15–US$2.29 per diluted share while issuing second-quarter EPS guidance of US$0.44–US$0.46. The company attributed the higher full-year guidance midpoint mainly to gains on asset sales and better-than-expected portfolio performance, underscoring how capital recycling and operating execution are feeding directly into...

Recent performance snapshot GEO Group (GEO) has been drawing attention after a recent stretch of strong share price gains, with the stock up over the past week, month and past 3 months, prompting closer scrutiny of its fundamentals. See our latest analysis for GEO Group. The recent 7 day share price return of 17.12% and 90 day share price return of 35.07% add to a strong upward move. This is the case even though the 1 year total shareholder return is down 16.82% and the 3 year total...

OPENLANE (OPLN) drew fresh attention after reporting first quarter 2026 results with higher revenue and net income than a year earlier, and raising full year earnings guidance. Analysts responded by increasing their estimates. See our latest analysis for OPENLANE. The raised guidance and stronger first quarter appear to have contributed to momentum, with a 30 day share price return of 27.62% and a year to date share price return of 29.72%. The 3 year total shareholder return of 151.76% points...

Investors in 4D Molecular Therapeutics, Inc. ( NASDAQ:FDMT ) had a good week, as its shares rose 7.4% to close at...

Federal Signal (FSS) drew fresh attention after reporting first quarter 2026 results, with sales of US$625.6 million and net income of US$70.4 million, along with a higher full year net sales outlook. See our latest analysis for Federal Signal. The Q1 2026 earnings and raised sales outlook came as the share price edged to US$118.33, with the stock showing modest positive share price momentum this year and a strong multi year total shareholder return profile. If this kind of steady compounding...

In early May 2026, Trimble reported first-quarter revenue of US$939.9 million and net income of US$98.9 million, completed a US$391.78 million buyback program, and raised both its full-year 2026 revenue and GAAP earnings per share guidance. Alongside these updates, Trimble highlighted a new integration between its SketchUp 3D modeling software and Anthropic’s Claude AI assistant, signaling a push to make advanced design workflows more accessible through natural-language interaction. We’ll...

Stellar Bancorp’s latest earnings snapshot Stellar Bancorp (STEL) recently reported first quarter results, highlighting net interest income of US$105.93 million and net income of US$26.97 million compared with the same period last year, drawing fresh attention to the stock. See our latest analysis for Stellar Bancorp. At a share price of US$37.46, Stellar Bancorp has delivered a year to date share price return of 21.78% and a 1 year total shareholder return of 40.98%. However, the 90 day...

Oscar Health (OSCR) is back in focus after reporting record first quarter 2026 earnings, with net income of US$679 million and diluted EPS of US$2.07, while management reaffirmed full year guidance. See our latest analysis for Oscar Health. The stock has reacted strongly to the record Q1 result, with a 30 day share price return of 47.47% and a 90 day gain of 65.45%. The 3 year total shareholder return of 196.80% contrasts with a weaker 5 year record, suggesting momentum is currently building...

Shareholders in Blue Bird Corporation ( NASDAQ:BLBD ) may be thrilled to learn that the analysts have just delivered a...